<<<"is it your friends looking for stop limits today?">>>
I dont look at anything day-to-day. And I dont do "stops" just an amateur. Any sophistication stops at calls/puts.
Realistically, painful though it may be (sub $3 now) I would dump IDIX and put my money elsewhere. Their one drug Tyzeka is the ultimate commercial dog, and it really has an extraordinarily shallow pipe-line.
Also the chances that Novartis will buy them is extremely low, when they have delivered so little.
There are plenty of other biotechs that will do well this year, I could name half-a-dozen.